Leidos, formerly known as Science Applications International Corporation (SAIC), is an American defense, aviation, information technology (Lockheed Martin IS&GS), and biomedical research company headquartered in Reston, Virginia, that provides scientific, engineering, systems integration, and technical services.
| Revenue (TTM) | $17.80B |
| Gross Profit (TTM) | $3.14B |
| EBITDA | $2.41B |
| Operating Margin | 12.00% |
| Return on Equity | 28.30% |
| Return on Assets | 9.08% |
| Revenue/Share (TTM) | $142.36 |
| Book Value | $42.40 |
| Price-to-Book | 3.20 |
| Price-to-Sales (TTM) | 0.91 |
| EV/Revenue | 1.264 |
| EV/EBITDA | 9.64 |
| Quarterly Earnings Growth (YoY) | 16.30% |
| Quarterly Revenue Growth (YoY) | 3.60% |
| Shares Outstanding | $122.00M |
| Float | $121.08M |
| % Insiders | 0.57% |
| % Institutions | 86.73% |
Volatility is currently expanding
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
New platform helps organizations govern AI agents from different vendors and keep people in control of key decisions. RESTON, Va.
Leidos NYSE: LDOS reported third-quarter 2026 results marked by higher revenue, earnings growth and strong cash generation, while management highlighted momentum in defense technology, homeland security and energy businesses as offsets to changes in its Veterans Benefits Administration disability exam work.
LDOS beats Q3 earnings estimates by 19.1% but misses revenue forecasts, raising its 2026 EPS and cash flow guidance while cutting sales outlook.
The headline numbers for Leidos (LDOS) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Leidos (LDOS) came out with quarterly earnings of $3.62 per share, beating the Zacks Consensus Estimate of $3.04 per share. This compares to earnings of $3.05 per share a year ago.
Revenues of $4.6 billion, up 4% year-over-year Net income of $413 million or $3.28 per diluted share Adjusted EBITDA (non-GAAP) of $644 million and Adjusted EBITDA margin (non-GAAP) of 13.9% Non-GAAP Diluted Earnings per Share of $3.62, up 19% year-over-year Cash Flows from Operations of $523 million; Non-GAAP Free Cash Flow of $476 million RESTON, Va., Nov. 3, 2026 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS) today reported financial results for the third quarter of fiscal year 2026, highlighted by robust revenue growth and free cash flow generation.
RESTON, Va., Nov. 2, 2026 /PRNewswire/ -- Leidos (NYSE: LDOS) is moving to strengthen the U.S. missile industrial base and prepare for production of thousands of affordable long-range cruise missiles, bringing together key missile-component suppliers to develop and scale production of its new Low-Cost Containerized Missile (LCCM) and the combat-proven AGM-190A Havoc Spear missile.
LDOS' Q3 results may benefit from rising defense demand, contract wins and AI initiatives, while healthcare revenue pressure and higher interest costs pose challenges.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LDOS and any ticker you trade — then tracks every position and per-strategy win rate.
